Reactive Airway Disease (RAD)

What is Reactive airway disease?

Reactive airway disease (RAD) is a descriptive term used by clinicians—especially in pediatric practice—to refer to a condition in which the airways are overly responsive to various stimuli, leading to reversible narrowing (bronchoconstriction). While the phrase is not a formal diagnosis, it often serves as a placeholder before a more specific condition (such as asthma or bronchitis) is confirmed.

People with RAD experience episodes of wheezing, coughing, shortness of breath, and chest tightness that improve with bronchodilator medication or spontaneously. The underlying mechanism is airway hyper‑responsiveness, meaning the smooth muscle surrounding the bronchi contracts more readily than normal when triggered.

Because RAD can be the first manifestation of asthma or other chronic lung diseases, early recognition and proper follow‑up are essential.

Common Causes

RAD is not a disease itself; rather, it is a reaction to a variety of irritants or health conditions. The most frequent precipitants include:

• Viral upper respiratory infections (e.g., rhinovirus, RSV) – the classic trigger in children.
• Allergic exposure – pollen, pet dander, dust mites, molds.
• Environmental irritants – cigarette smoke, air pollution, strong odors, chemical fumes.
• Exercise‑induced bronchoconstriction – especially in cold, dry air.
• Gastro‑esophageal reflux disease (GERD) – acid reaching the airway can provoke reflex bronchospasm.
• Medications – beta‑blockers, aspirin, non‑steroidal anti‑inflammatory drugs (NSAIDs) in susceptible individuals.
• Cold air exposure – rapid temperature changes can trigger airway spasm.
• Stress or strong emotions – crying, anxiety, or panic attacks may worsen symptoms.
• Occupational exposures – grain dust, animal dander, chemicals in factories.
• Second‑hand smoke – especially important in toddlers and infants.

Associated Symptoms

RAD episodes often present with a cluster of respiratory signs that overlap with asthma. Common accompanying symptoms include:

• Wheezing – a high‑pitched whistling sound during exhalation.
• Cough – frequently dry and worse at night or early morning.
• Shortness of breath (dyspnea) or a feeling of “tightness” in the chest.
• Increased mucus production or post‑nasal drip.
• Chest “tightness” that may feel like a band around the chest.
• Reduced exercise tolerance – children may stop playing earlier than peers.
• Sleep disturbance due to nighttime coughing or wheezing.

When to See a Doctor

Most children and adults with occasional wheezing recover without medical intervention, but you should seek professional care if:

• Symptoms persist longer than 2–3 days or recur frequently.
• The wheeze does not improve with a short‑acting bronchodilator (e.g., albuterol).
• There is difficulty speaking in full sentences due to breathlessness.
• You notice a persistent cough that disrupts sleep.
• There is a fever > 38.5 °C (101.3 °F) accompanying the respiratory symptoms.
• Recurrent episodes occur after exposure to the same trigger (e.g., pet, pollen).
• Previous diagnosis of asthma or chronic lung disease has not been made, yet symptoms are suggestive.
• Any new symptom such as chest pain, bluish lips/skin, or swelling of the face.

Diagnosis

Because “reactive airway disease” is a clinical descriptor, physicians use a combination of history, physical exam, and objective testing to identify the underlying cause.

Clinical History

• Onset, frequency, and duration of wheezing or coughing.
• Known triggers (allergens, infections, exercise, smoke).
• Family history of asthma, eczema, or allergic rhinitis.
• Response to previous bronchodilators or steroids.

Physical Examination

• Auscultation for wheezes, crackles, or decreased breath sounds.
• Assessment of growth, especially in children (poor weight gain may suggest chronic airway disease).
• Examination for allergic signs – nasal polyps, eczema, conjunctivitis.

Objective Tests

• Spirometry (or infant pulmonary function testing) – measures forced expiratory volume (FEV₁) and reversibility after bronchodilator.
• Peak Expiratory Flow (PEF) – useful for monitoring at home.
• Bronchoprovocation testing (e.g., methacholine challenge) – confirms airway hyper‑responsiveness.
• Allergy testing – skin prick or serum IgE to identify specific allergens.
• Chest radiograph – usually normal; performed to rule out pneumonia, foreign body, or structural anomalies.

Laboratory work‑up (CBC, eosinophil count) may be ordered if an allergic component is suspected.

Treatment Options

Treatment is individualized based on severity, frequency of episodes, and identified triggers.

Medication

• Short‑acting beta‑agonists (SABA) – albuterol inhaler; first‑line for acute relief.
• Inhaled corticosteroids (ICS) – low‑dose fluticasone or budesonide for persistent symptoms.
• Leukotriene receptor antagonists – montelukast, especially if allergic rhinitis co‑exists.
• Long‑acting beta‑agonists (LABA) – combined with ICS for moderate‑to‑severe disease (e.g., salmeterol/fluticasone).
• Systemic steroids – oral prednisone short course for severe exacerbations.
• Chromones (e.g., cromolyn sodium) – prophylactic use for exercise‑induced symptoms.

Home and Lifestyle Management

• Use a spacer with metered‑dose inhalers to improve drug delivery.
• Maintain a peak flow diary to track patterns and early decline.
• Avoid known irritants: smoke, strong fragrances, and indoor pollutants.
• Implement allergen‑reduction strategies (humidifiers, HEPA filters, pillow‑case changes).
• Encourage regular, moderate exercise; consider a warm‑up routine for exercise‑induced RAD.
• Ensure flu and pneumococcal vaccinations are up‑to‑date.

When Medications Are Adjusted

If symptoms occur > 2 times per week or interfere with sleep, step‑up therapy per the National Asthma Education and Prevention Program (NAEPP) guidelines is recommended, even if the final diagnosis remains “RAD.”

Prevention Tips

Because many triggers are modifiable, proactive measures can reduce the frequency of RAD episodes:

• Eliminate tobacco exposure – no smoking inside the home or car.
• Control indoor allergens – keep humidity < 50 %, wash bedding weekly in hot water, remove carpets if possible.
• Manage seasonal allergies – antihistamines or nasal steroids during pollen spikes.
• Vaccinate – annual influenza vaccine and COVID‑19 boosters for at‑risk individuals.
• Promptly treat viral colds – hand‑washing, avoiding close contact with infected people.
• Use protective equipment – masks in high‑pollution areas, respirators when exposed to chemicals.
• Maintain a healthy weight – obesity can worsen airway inflammation.
• Stay hydrated – thin mucus secretions and improve airway clearance.
• Educate caregivers – recognize early signs of an attack and know how to use inhalers correctly.

Emergency Warning Signs

Key Take‑aways

• Reactive airway disease describes airway hyper‑responsiveness that often precedes a formal asthma diagnosis.
• Common triggers include viral infections, allergens, smoke, cold air, and certain medications.
• Typical symptoms are wheezing, cough, and shortness of breath that improve with bronchodilators.
• Seek medical evaluation if episodes are frequent, severe, or unresponsive to rescue medication.
• Diagnosis combines history, physical exam, spirometry, and sometimes allergy testing.
• Treatment ranges from short‑acting inhalers for acute relief to inhaled steroids for long‑term control.
• Prevention focuses on trigger avoidance, vaccination, and maintaining overall lung health.
• Know the emergency warning signs—these require immediate emergency care.

---

References:

1. Mayo Clinic. “Reactive airway disease.” Accessed May 2026. https://www.mayoclinic.org/diseases-conditions/reactive-airway-disease/symptoms-causes/syc-20355887
2. NIH National Heart, Lung, and Blood Institute. “Asthma Management Guidelines.” 2023. https://www.nhlbi.nih.gov/health-topics/asthma
3. CDC. “Asthma — Managing Symptoms.” 2024. https://www.cdc.gov/asthma/default.htm
4. Cleveland Clinic. “Bronchial Hyperresponsiveness (Reactive Airway Disease).” 2025. https://my.clevelandclinic.org/health/diseases/15700-bronchial-hyperresponsiveness
5. World Health Organization. “Air quality and health.” 2022. https://www.who.int/health-topics/air-pollution#tab=tab_1